Ayala Pharmaceuticals Inc. (ADXS)
OTCMKTS: ADXS · Delayed Price · USD
0.550
0.00 (0.00%)
Apr 26, 2024, 9:30 AM EDT - Market open

Ayala Pharmaceuticals Market Cap

Ayala Pharmaceuticals has a market cap or net worth of $23.66 million as of April 26, 2024. Its market cap has decreased by -58.71% in one year.

Market Cap
23.66M
Enterprise Value
27.10M
1-Year Change
-58.71%
Ranking
n/a
Category
Stock Price
$0.55

Market Cap Chart

Since July 28, 2005, Ayala Pharmaceuticals's market cap has increased from $16.70M to $23.66M, an increase of 41.69%. That is a compound annual growth rate of 2.09%.

History

DateMarket Cap% Change
Jun 6, 20227.30M-18.89%
Jun 3, 20229.00M-14.29%
Jun 2, 202210.50M2.94%
Jun 1, 202210.20M10.87%
May 31, 20229.20M-
May 27, 20229.20M3.37%
May 26, 20228.90M-6.32%
May 25, 20229.50M2.15%
May 24, 20229.30M3.33%
May 23, 20229.00M-9.09%
May 20, 20229.90M4.21%
May 19, 20229.50M-5.00%
May 18, 202210.00M1.01%
May 17, 20229.90M3.13%
May 16, 20229.60M3.23%
May 13, 20229.30M-8.82%
May 12, 202210.20M7.37%
May 11, 20229.50M-3.06%
May 10, 20229.80M-3.92%
May 9, 202210.20M-14.29%
May 6, 202211.90M-1.65%
May 5, 202212.10M-7.63%
May 4, 202213.10M5.65%
May 3, 202212.40M5.98%
May 2, 202211.70M-1.68%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 689.18B
Novo Nordisk 562.24B
UnitedHealth Group 455.31B
Johnson & Johnson 353.80B
Merck & Co. 331.07B
AbbVie 296.21B
AstraZeneca 232.58B
Thermo Fisher 218.24B
Market Cap Rankings